Celator Pharmaceuticals: Progressing The Paradigm Of Combination Chemotherapy Seeking Alpha, 29 Feb 2016 Celator Pharmaceuticals (NASDAQ: CPXX ) is a clinical-stage drug development company currently focused on combination therapies…